Agilon Health (NYSE:AGL) Reaches New 52-Week High – Still a Buy?

Agilon Health, Inc. (NYSE:AGL)’s stock price hit a new 52-week high on Monday . The company traded as high as $119.25 and last traded at $117.7050, with a volume of 554 shares trading hands. The stock had previously closed at $119.25.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Wells Fargo & Company reissued an “overweight” rating and set a $72.00 price objective (up from $37.50) on shares of Agilon Health in a report on Friday, May 8th. Barclays raised shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 target price on the stock in a report on Tuesday, May 26th. Weiss Ratings cut shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Citigroup reiterated a “neutral” rating and set a $80.00 target price (up from $18.75) on shares of Agilon Health in a research report on Friday, May 15th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Five investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $58.73.

Agilon Health Price Performance

The stock has a fifty day moving average of $75.82 and a two-hundred day moving average of $37.44. The stock has a market capitalization of $2.04 billion, a price-to-earnings ratio of -5.69 and a beta of 3.00. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. As a group, equities research analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Institutional Investors Weigh In On Agilon Health

A number of hedge funds have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Agilon Health by 3.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after acquiring an additional 7,209 shares during the last quarter. Dynamic Technology Lab Private Ltd grew its stake in shares of Agilon Health by 28.4% during the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after purchasing an additional 10,424 shares during the last quarter. Apollon Wealth Management LLC grew its stake in shares of Agilon Health by 17.4% during the fourth quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock valued at $57,000 after purchasing an additional 12,193 shares during the last quarter. Legal & General Group Plc increased its holdings in shares of Agilon Health by 4.1% in the second quarter. Legal & General Group Plc now owns 346,031 shares of the company’s stock valued at $796,000 after purchasing an additional 13,700 shares in the last quarter. Finally, Symphony Financial Services Inc. increased its holdings in shares of Agilon Health by 51.6% in the third quarter. Symphony Financial Services Inc. now owns 47,000 shares of the company’s stock valued at $48,000 after purchasing an additional 16,000 shares in the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.